Suppression of Foxo1 activity and down-modulation of CD62L (L-selectin) in HIV-1 infected resting CD4 T cells

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Trinité, Benjamin ^a   Chan, Chi N ^a   Lee, Caroline S ^a   Mahajan, Saurabh ^a   Luo, Yang ^b   Muesing, Mark A ^b   Folkvord, Joy M ^c   Pham, Michael ^c,d   Connick, Elizabeth ^c   Levy, David N ^a  

^a NEW YORK UNIVERSITY   (United States)

^b AARON DIAMOND AIDS RESEARCH CENTER   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AS 1842856; CD52 ANTIGEN; CD69 ANTIGEN; CELL PROTEIN; CHEMOKINE RECEPTOR CCR5; CYCLIN D2; CYCLIN DEPENDENT KINASE INHIBITOR 1; INTERLEUKIN 7 RECEPTOR ALPHA; KRUPPEL LIKE FACTOR 2; L SELECTIN; MESSENGER RNA; MYC PROTEIN; PROTEIN FAM65B; PROTEIN INHIBITOR; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE 1 PHOSPHATE RECEPTOR 1; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG; 5-AMINO-7-(CYCLOHEXYLAMINO)-1-ETHYL-6-FLUORO-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, HUMAN; INTERLEUKIN 7 RECEPTOR; INTERLEUKIN-7 RECEPTOR, ALPHA CHAIN; KLF2 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; QUINOLONE DERIVATIVE;

ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CHILD; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN TISSUE; IN VITRO STUDY; INHIBITION KINETICS; NONHUMAN; NUCLEAR REPROGRAMMING; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE ACTIVATION; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS REPLICATION; BIOSYNTHESIS; DRUG EFFECTS; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; LYMPHOID TISSUE; PATHOGENICITY; PATHOLOGY; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

CD4-POSITIVE T-LYMPHOCYTES; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HIV INFECTIONS; HIV-1; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; L-SELECTIN; LYMPHOCYTE ACTIVATION; LYMPHOID TISSUE; QUINOLONES; RECEPTORS, INTERLEUKIN-7; VIRUS REPLICATION;

EID: 84908028469     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110719     Document Type: Article

References (138)

1. Zhang ZQ, Wietgrefe SW, Li Q, Shore MD, Duan L, et al. (2004) Roles of substrate availability and infection of resting and activated CD4+ T cells in transmission and acute simian immunodeficiency virus infection. Proc Natl Acad Sci U S A 101: 5640-5645.
2. Ostrowski MA, Chun TW, Justement SJ, Motola I, Spinelli MA, et al. (1999) Both memory and CD45RA+/CD62L+ naive CD4(+) T cells are infected in human immunodeficiency virus type 1-infected individuals. J Virol 73: 6430-6435.
3. Zhang Z, Schuler T, Zupancic M, Wietgrefe S, Staskus KA, et al. (1999) Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 286: 1353-1357.
4. Schacker T, Little S, Connick E, Gebhard K, Zhang ZQ, et al. (2001) Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection. J Infect Dis 183: 555-562.
5. Li Q, Duan L, Estes JD, Ma ZM, Rourke T, et al. (2005) Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 434: 1148-1152.
6. Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, et al. (2005) Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434: 1093-1097.
7. Hatziioannou T, Del Prete GQ, Keele BF, Estes JD, McNatt MW, et al. (2014) HIV-1-induced AIDS in monkeys. Science 344: 1401-1405.
8. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, et al. (1990) HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61: 213-222.
9. Pan X, Baldauf HM, Keppler OT, Fackler OT (2013) Restrictions to HIV-1 replication in resting CD4+ T lymphocytes. Cell Res 23: 876-885.
10. Zack JA, Kim SG, Vatakis DN (2013) HIV restriction in quiescent CD4(+) T cells. Retrovirology 10: 37.
11. Vella A, Teague TK, Ihle J, Kappler J, Marrack P (1997) Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: stat6 is probably not required for the effect of IL-4. J Exp Med 186: 325-330.
12. Gomez J, Martinez AC, Gonzalez A, Garcia A, Rebollo A (1998) The Bcl-2 gene is differentially regulated by IL-2 and IL-4: role of the transcription factor NF-AT. Oncogene 17: 1235-1243.
13. Aronica MA, Goenka S, Boothby M (2000) IL-4-dependent induction of BCL- 2 and BCL-X(L)IN activated T lymphocytes through a STAT6- and pi 3- kinase-independent pathway. Cytokine 12: 578-587.
14. Vella AT, Dow S, Potter TA, Kappler J, Marrack P (1998) Cytokine-induced survival of activated T cells in vitro and in vivo. Proc Natl Acad Sci U S A 95: 3810-3815.
15. Boise LH, Minn AJ, June CH, Lindsten T, Thompson CB (1995) Growth factors can enhance lymphocyte survival without committing the cell to undergo cell division. Proc Natl Acad Sci U S A 92: 5491-5495.
16. Estes JD (2013) Pathobiology of HIV/SIV-associated changes in secondary lymphoid tissues. Immunol Rev 254: 65-77.
17. Rathmell JC, Farkash EA, Gao W, Thompson CB (2001) IL-7 enhances the survival and maintains the size of naive T cells. J Immunol 167: 6869-6876.
18. Kinter A, Moorthy A, Jackson R, Fauci AS (2003) Productive HIV infection of resting CD4+ T cells: role of lymphoid tissue microenvironment and effect of immunomodulating agents. AIDS Res Hum Retroviruses 19: 847-856.
19. Unutmaz D, KewalRamani VN, Marmon S, Littman DR (1999) Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes. J Exp Med 189: 1735-1746.
20. Ducrey-Rundquist O, Guyader M, Trono D (2002) Modalities of interleukin-7- induced human immunodeficiency virus permissiveness in quiescent T lymphocytes. J Virol 76: 9103-9111.
21. Steffens CM, Managlia EZ, Landay A, Al-Harthi L (2002) Interleukin-7- treated naive T cells can be productively infected by T-cell-adapted and primary isolates of human immunodeficiency virus 1. Blood 99: 3310-3318.
22. Trinité B, Ohlson EC, Voznesensky I, Rana SP, Chan CN, et al. (2013) An HIV-1 replication pathway utilizing reverse transcription products that fail to integrate. J Virol 87: 12701-12720.
23. Surh CD, Sprent J (2008) Homeostasis of naive and memory T cells. Immunity 29: 848-862.
24. Bradley LM, Haynes L, Swain SL (2005) IL-7: maintaining T-cell memory and achieving homeostasis. Trends Immunol 26: 172-176.
25. Yoder A, Yu D, Dong L, Iyer SR, Xu X, et al. (2008) HIV envelope-CXCR4 signaling activates cofilin to overcome cortical actin restriction in resting CD4 T cells. Cell 134: 782-792.
26. Wolf D, Witte V, Laffert B, Blume K, Stromer E, et al. (2001) HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals. Nat Med 7: 1217-1224.
27. Zhou F, Xue M, Qin D, Zhu X, Wang C, et al. (2013) HIV-1 Tat promotes Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6-induced angiogenesis and tumorigenesis by regulating PI3K/PTEN/AKT/GSK-3beta signaling pathway. PLoS One 8: e53145.
28. Swann SA, Williams M, Story CM, Bobbitt KR, Fleis R, et al. (2001) HIV-1 Nef blocks transport of MHC class I molecules to the cell surface via a PI 3- kinase-dependent pathway. Virology 282: 267-277.
29. Wu Y, Marsh JW (2001) Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA. Science 293: 1503-1506.
30. Vatakis DN, Nixon CC, Zack JA (2010) Quiescent T cells and HIV: an unresolved relationship. Immunol Res 48: 110-121.
31. Yusuf I, Fruman DA (2003) Regulation of quiescence in lymphocytes. Trends Immunol 24: 380-386.
32. Tzachanis D, Lafuente EM, Li L, Boussiotis VA (2004) Intrinsic and extrinsic regulation of T lymphocyte quiescence. Leuk Lymphoma 45: 1959-1967.
33. Carrette F, Fabre S, Bismuth G (2009) FOXO1, T-cell trafficking and immune responses. Adv Exp Med Biol 665: 3-16.
34. Dejean AS, Hedrick SM, Kerdiles YM (2011) Highly specialized role of Forkhead box O transcription factors in the immune system. Antioxid Redox Signal 14: 663-674.
35. Hedrick SM, Hess Michelini R, Doedens AL, Goldrath AW, Stone EL (2012) FOXO transcription factors throughout T cell biology. Nat Rev Immunol 12: 649-661.
36. Medema RH, Kops GJ, Bos JL, Burgering BM (2000) AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404: 782-787.
37. Coffer PJ, Burgering BM (2004) Forkhead-box transcription factors and their role in the immune system. Nat Rev Immunol 4: 889-899.
38. Cui M, Huang Y, Zhao Y, Zheng J (2009) New insights for FOXO and cell-fate decision in HIV infection and HIV associated neurocognitive disorder. Adv Exp Med Biol 665: 143-159.
39. van Grevenynghe J, Cubas RA, DaFonseca S, Metcalf T, Tremblay CL, et al. (2012) Foxo3a: an integrator of immune dysfunction during HIV infection. Cytokine Growth Factor Rev 23: 215-221.
40. van Grevenynghe J, Procopio FA, He Z, Chomont N, Riou C, et al. (2008) Transcription factor FOXO3a controls the persistence of memory CD4(+) T cells during HIV infection. Nat Med 14: 266-274.
41. Leenders H, Whiffield S, Benoist C, Mathis D (2000) Role of the forkhead transcription family member, FKHR, in thymocyte differentiation. Eur J Immunol 30: 2980-2990.
42. Coffer PJ (2003) Transcriptional regulation of lymphocyte quiescence: as cunning as a FOX. Trends Immunol 24: 470-471; author reply 471.
43. van der Horst A, Burgering BM (2007) Stressing the role of FoxO proteins in lifespan and disease. Nat Rev Mol Cell Biol 8: 440-450.
44. Ouyang W, Liao W, Luo CT, Yin N, Huse M, et al. (2012) Novel Foxo1-dependent transcriptional programs control T(reg) cell function. Nature 491: 554-559.
45. Fabre S, Carrette F, Chen J, Lang V, Semichon M, et al. (2008) FOXO1 regulates L-Selectin and a network of human T cell homing molecules downstream of phosphatidylinositol 3-kinase. J Immunol 181: 2980-2989.
46. Tzivion G, Dobson M, Ramakrishnan G (2011) FoxO transcription factors; Regulation by AKT and 14-3-3 proteins. Biochim Biophys Acta 1813: 1938- 1945.
47. van der Vos KE, Coffer PJ (2008) FOXO-binding partners: it takes two to tango. Oncogene 27: 2289-2299.
48. Kerdiles YM, Beisner DR, Tinoco R, Dejean AS, Castrillon DH, et al. (2009) Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. Nat Immunol 10: 176-184.
49. Ouyang W, Beckett O, Flavell RA, Li MO (2009) An essential role of the Forkhead-box transcription factor Foxo1 in control of T cell homeostasis and tolerance. Immunity 30: 358-371.
50. Hedrick SM (2009) The cunning little vixen: Foxo and the cycle of life and death. Nat Immunol 10: 1057-1063.
51. Sinclair LV, Finlay D, Feijoo C, Cornish GH, Gray A, et al. (2008) Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking. Nat Immunol 9: 513-521.
52. Butcher EC, Picker LJ (1996) Lymphocyte homing and homeostasis. Science 272: 60-66.
53. Galkina E, Tanousis K, Preece G, Tolaini M, Kioussis D, et al. (2003) L-selectin shedding does not regulate constitutive T cell trafficking but controls the migration pathways of antigen-activated T lymphocytes. J Exp Med 198: 1323-1335.
54. Venturi GM, Tu L, Kadono T, Khan AI, Fujimoto Y, et al. (2003) Leukocyte migration is regulated by L-selectin endoproteolytic release. Immunity 19: 713-724.
55. Chao CC, Jensen R, Dailey MO (1997) Mechanisms of L-selectin regulation by activated T cells. J Immunol 159: 1686-1694.
56. Bai A, Hu H, Yeung M, Chen J (2007) Kruppel-like factor 2 controls T cell trafficking by activating L-selectin (CD62L) and sphingosine-1-phosphate receptor 1 transcription. J Immunol 178: 7632-7639.
57. Preston GC, Feijoo-Carnero C, Schurch N, Cowling VH, Cantrell DA (2013) The impact of KLF2 modulation on the transcriptional program and function of CD8 T cells. PLoS One 8: e77537.
58. Kuo CT, Veselits ML, Leiden JM (1997) LKLF: A transcriptional regulator of single-positive T cell quiescence and survival. Science 277: 1986-1990.
59. Schober SL, Kuo CT, Schluns KS, Lefrancois L, Leiden JM, et al. (1999) Expression of the transcription factor lung Kruppel-like factor is regulated by cytokines and correlates with survival of memory T cells in vitro and in vivo. J Immunol 163: 3662-3667.
60. Carlson CM, Endrizzi BT, Wu J, Ding X, Weinreich MA, et al. (2006) Kruppel-like factor 2 regulates thymocyte and T-cell migration. Nature 442: 299-302.
61. Richardson MW, Jadlowsky J, Didigu CA, Doms RW, Riley JL (2012) Kruppel-like factor 2 modulates CCR5 expression and susceptibility to HIV-1 infection. J Immunol 189: 3815-3821.
62. Haaland RE, Yu W, Rice AP (2005) Identification of LKLF-regulated genes in quiescent CD4+ T lymphocytes. Mol Immunol 42: 627-641.
63. Schmidt M, Fernandez de Mattos S, van der Horst A, Klompmaker R, Kops GJ, et al. (2002) Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D. Mol Cell Biol 22: 7842-7852.
64. Rougerie P, Largeteau Q, Megrelis L, Carrette F, Lejeune T, et al. (2013) Fam65b is a new transcriptional target of FOXO1 that regulates RhoA signaling for T lymphocyte migration. J Immunol 190: 748-755.
65. Hung CH, Thomas L, Ruby CE, Atkins KM, Morris NP, et al. (2007) HIV-1 Nef assembles a Src family kinase-ZAP-70/Syk-PI3K cascade to downregulate cell-surface MHC-I. Cell Host Microbe 1: 121-133.
66. Marodon G, Landau NR, Posnett DN (1999) Altered expression of CD4, CD54, CD62L, and CCR5 in primary lymphocytes productively infected with the human immunodeficiency virus. AIDS Res Hum Retroviruses 15: 161-171.
67. Ramirez PW, Famiglietti M, Sowrirajan B, DePaula-Silva AB, Rodesch C, et al. (2014) Downmodulation of CCR7 by HIV-1 Vpu Results in Impaired Migration and Chemotactic Signaling within CD4(+) T Cells. Cell Rep 7: 2019-2030.
68. Levy DN, Fernandes LS, Williams WV, Weiner DB (1993) Induction of cell differentiation by human immunodeficiency virus 1 vpr. Cell 72: 541-550.
69. Moutsopoulos NM, Vazquez N, Greenwell-Wild T, Ecevit I, Horn J, et al. (2006) Regulation of the tonsil cytokine milieu favors HIV susceptibility. J Leukoc Biol 80: 1145-1155.
70. Wang Y, Zhang AC, Ni Z, Herrera A, Walcheck B (2010) ADAM17 activity and other mechanisms of soluble L-selectin production during death receptor-induced leukocyte apoptosis. J Immunol 184: 4447-4454.
71. Scheller J, Chalaris A, Garbers C, Rose-John S (2011) ADAM17: a molecular switch to control inflammation and tissue regeneration. Trends Immunol 32: 380-387.
72. Marschner S, Freiberg BA, Kupfer A, Hunig T, Finkel TH (1999) Ligation of the CD4 receptor induces activation-independent down-regulation of Lselectin. Proc Natl Acad Sci U S A 96: 9763-9768.
73. Wang J, Marschner S, Finkel TH (2004) CXCR4 engagement is required for HIV-1-induced L-selectin shedding. Blood 103: 1218-1221.
74. Wang L, Robb CW, Cloyd MW (1997) HIV induces homing of resting T lymphocytes to lymph nodes. Virology 228: 141-152.
75. Oswald-Richter K, Grill SM, Leelawong M, Unutmaz D (2004) HIV infection of primary human T cells is determined by tunable thresholds of T cell activation. Eur J Immunol 34: 1705-1714.
76. Francois F, Klotman ME (2003) Phosphatidylinositol 3-kinase regulates human immunodeficiency virus type 1 replication following viral entry in primary CD4+ T lymphocytes and macrophages. J Virol 77: 2539-2549.
77. Kutsch O, Benveniste EN, Shaw GM, Levy DN (2002) Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency. J Virol 76: 8776-8786.
78. Nagashima T, Shigematsu N, Maruki R, Urano Y, Tanaka H, et al. (2010) Discovery of novel forkhead box O1 inhibitors for treating type 2 diabetes: improvement of fasting glycemia in diabetic db/db mice. Mol Pharmacol 78: 961-970.
79. Shore AM, White PC, Hui RC, Essafi A, Lam EW, et al. (2006) Epstein-Barr virus represses the FoxO1 transcription factor through latent membrane protein 1 and latent membrane protein 2A. J Virol 80: 11191-11199.
80. Fu Z, Tindall DJ (2008) FOXOs, cancer and regulation of apoptosis. Oncogene 27: 2312-2319.
81. Huang H, Tindall DJ (2011) Regulation of FOXO protein stability via ubiquitination and proteasome degradation. Biochim Biophys Acta 1813: 1961-1964.
82. Calnan DR, Brunet A (2008) The FoxO code. Oncogene 27: 2276-2288.
83. Misse D, Gajardo J, Oblet C, Religa A, Riquet N, et al. (2005) Soluble HIV-1 gp120 enhances HIV-1 replication in non-dividing CD4+ T cells, mediated via cell signaling and Tat cofactor overexpression. AIDS 19: 897-905.
84. Borgatti P, Zauli G, Colamussi ML, Gibellini D, Previati M, et al. (1997) Extracellular HIV-1 Tat protein activates phosphatidylinositol 3- and Akt/ PKB kinases in CD4+ T lymphoblastoid Jurkat cells. Eur J Immunol 27: 2805-2811.
85. Siekevitz M, Feinberg MB, Holbrook N, Wong-Staal F, Greene WC (1987) Activation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type I. Proc Natl Acad Sci U S A 84: 5389-5393.
86. Rhee SS, Marsh JW (1994) HIV-1 Nef activity in murine T cells. CD4 modulation and positive enhancement. J Immunol 152: 5128-5134.
87. Ott M, Emiliani S, Van Lint C, Herbein G, Lovett J, et al. (1997) Immune hyperactivation of HIV-1-infected T cells mediated by Tat and the CD28 pathway. Science 275: 1481-1485.
88. Schrager JA, Marsh JW (1999) HIV-1 Nef increases T cell activation in a stimulus-dependent manner. Proc Natl Acad Sci U S A 96: 8167-8172.
89. Wang JK, Kiyokawa E, Verdin E, Trono D (2000) The Nef protein of HIV-1 associates with rafts and primes T cells for activation. Proc Natl Acad Sci U S A 97: 394-399.
90. Luo HR, Hattori H, Hossain MA, Hester L, Huang Y, et al. (2003) Akt as a mediator of cell death. Proc Natl Acad Sci U S A 100: 11712-11717.
91. Alexander W (2011) Inhibiting the akt pathway in cancer treatment: three leading candidates. P T 36: 225-227.
92. Denisova OV, Soderholm S, Virtanen S, Von Schantz C, Bychkov D, et al. (2014) Akt Inhibitor MK2206 Prevents Influenza pH1N1 Virus Infection In Vitro. Antimicrob Agents Chemother 58: 3689-3696.
93. Li Z, Yan S, Attayan N, Ramalingam S, Thiele CJ (2012) Combination of an allosteric Akt Inhibitor MK-2206 with etoposide or rapamycin enhances the antitumor growth effect in neuroblastoma. Clin Cancer Res 18: 3603-3615.
94. Zhang X, Tang N, Hadden TJ, Rishi AK (2011) Akt, FoxO and regulation of apoptosis. Biochim Biophys Acta 1813: 1978-1986.
95. Pal SK, Reckamp K, Yu H, Figlin RA (2010) Akt inhibitors in clinical development for the treatment of cancer. Expert Opin Investig Drugs 19: 1355-1366.
96. Kim D, Sun M, He L, Zhou QH, Chen J, et al. (2010) A small molecule inhibits Akt through direct binding to Akt and preventing Akt membrane translocation. J Biol Chem 285: 8383-8394.
97. Kim Y, Hollenbaugh JA, Kim DH, Kim B (2011) Novel PI3K/Akt inhibitors screened by the cytoprotective function of human immunodeficiency virus type 1 Tat. PLoS One 6: e21781.
98. Chugh P, Bradel-Tretheway B, Monteiro-Filho CM, Planelles V, Maggirwar SB, et al. (2008) Akt inhibitors as an HIV-1 infected macrophage-specific antiviral therapy. Retrovirology 5: 11.
99. Zhang L, Chung C, Hu BS, He T, Guo Y, et al. (2000) Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy. J Clin Invest 106: 839-845.
100. Sedaghat AR, Siliciano JD, Brennan TP, Wilke CO, Siliciano RF (2007) Limits on replenishment of the resting CD4+ T cell reservoir for HIV in patients on HAART. PLoS Pathog 3: e122.
101. Eckstein DA, Penn ML, Korin YD, Scripture-Adams DD, Zack JA, et al. (2001) HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues. Immunity 15: 671-682.
102. Blaak H, van't Wout AB, Brouwer M, Hooibrink B, Hovenkamp E, et al. (2000) In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline. Proc Natl Acad Sci U S A 97: 1269-1274.
103. Rollins BJ (2008) Innocents abroad: regulating where naive T cells go. Nat Immunol 9: 233-235.
104. Schwab SR, Cyster JG (2007) Finding a way out: lymphocyte egress from lymphoid organs. Nat Immunol 8: 1295-1301.
105. Sebzda E, Zou Z, Lee JS, Wang T, Kahn ML (2008) Transcription factor KLF2 regulates the migration of naive T cells by restricting chemokine receptor expression patterns. Nat Immunol 9: 292-300.
106. Berstein G, Abraham RT (2008) Moving out: mobilizing activated T cells from lymphoid tissues. Nat Immunol 9: 455-457.
107. Ramaswamy S, Nakamura N, Sansal I, Bergeron L, Sellers WR (2002) A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell 2: 81-91.
108. Jiang G, Espeseth A, Hazuda DJ, Margolis DM (2007) c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter. J Virol 81: 10914-10923.
109. Garris CS, Blaho VA, Hla T, Han MH (2014) Sphingosine-1-phosphate receptor 1 signalling in T cells: trafficking and beyond. Immunology 142: 347-353.
110. Mudd JC, Murphy P, Manion M, Debernardo R, Hardacre J, et al. (2013) Impaired T-cell responses to sphingosine-1-phosphate in HIV-1 infected lymph nodes. Blood 121: 2914-2922.
111. Chu P, Pardo J, Zhao H, Li CC, Pali E, et al. (2003) Systematic identification of regulatory proteins critical for T-cell activation. J Biol 2: 21.
112. Shiow LR, Rosen DB, Brdickova N, Xu Y, An J, et al. (2006) CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440: 540-544.
113. Radulovic K, Rossini V, Manta C, Holzmann K, Kestler HA, et al. (2013) The early activation marker CD69 regulates the expression of chemokines and CD4 T cell accumulation in intestine. PLoS One 8: e65413.
114. Blazquez MV, Macho A, Ortiz C, Lucena C, Lopez-Cabrera M, et al. (1999) Extracellular HIV type 1 Tat protein induces CD69 expression through NFkappaB activation: possible correlation with cell surface Tat-binding proteins. AIDS Res Hum Retroviruses 15: 1209-1218.
115. Bankovich AJ, Shiow LR, Cyster JG (2010) CD69 suppresses sphingosine 1- phosophate receptor-1 (S1P1) function through interaction with membrane helix 4. J Biol Chem 285: 22328-22337.
116. Fulcher D, Wong S (1999) Carboxyfluorescein succinimidyl ester-based proliferative assays for assessment of T cell function in the diagnostic laboratory. Immunol Cell Biol 77: 559-564.
117. Seoane J, Le HV, Shen L, Anderson SA, Massague J (2004) Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117: 211-223.
118. Wu J, Lingrel JB (2004) KLF2 inhibits Jurkat T leukemia cell growth via upregulation of cyclin-dependent kinase inhibitor p21WAF1/CIP1. Oncogene 23: 8088-8096.
119. Tejera MM, Kim EH, Sullivan JA, Plisch EH, Suresh M (2013) FoxO1 controls effector-to-memory transition and maintenance of functional CD8 T cell memory. J Immunol 191: 187-199.
120. Buckley AF, Kuo CT, Leiden JM (2001) Transcription factor LKLF is sufficient to program T cell quiescence via a c-Myc-dependent pathway. Nat Immunol 2: 698-704.
121. Chowdhury IH, Wang XF, Landau NR, Robb ML, Polonis VR, et al. (2003) HIV-1 Vpr activates cell cycle inhibitor p21/Waf1/Cip1: a potential mechanism of G2/M cell cycle arrest. Virology 305: 371-377.
122. Amini S, Saunders M, Kelley K, Khalili K, Sawaya BE (2004) Interplay between HIV-1 Vpr and Sp1 modulates p21(WAF1) gene expression in human astrocytes. J Biol Chem 279: 46046-46056.
123. Vazquez N, Greenwell-Wild T, Marinos NJ, Swaim WD, Nares S, et al. (2005) Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation. J Virol 79: 4479-4491.
124. Rougerie P, Delon J (2012) Rho GTPases: masters of T lymphocyte migration and activation. Immunol Lett 142: 1-13.
125. Michel N, Allespach I, Venzke S, Fackler OT, Keppler OT (2005) The Nef protein of human immunodeficiency virus establishes superinfection immunity by a dual strategy to downregulate cell-surface CCR5 and CD4. Curr Biol 15: 714-723.
126. Landi A, Iannucci V, Nuffel AV, Meuwissen P, Verhasselt B (2011) One protein to rule them all: modulation of cell surface receptors and molecules by HIV Nef. Curr HIV Res 9: 496-504.
127. Gelderblom HC, Vatakis DN, Burke SA, Lawrie SD, Bristol GC, et al. (2008) Viral complementation allows HIV-1 replication without integration. Retrovirology 5: 60.
128. Duchesneau P, Gallagher E, Walcheck B, Waddell TK (2007) Up-regulation of leukocyte CXCR4 expression by sulfatide: an L-selectin-dependent pathway on CD4+ T cells. Eur J Immunol 37: 2949-2960.
129. Mueller SN, Gebhardt T, Carbone FR, Heath WR (2013) Memory T cell subsets, migration patterns, and tissue residence. Annu Rev Immunol 31: 137- 161.
130. Sallusto F, Geginat J, Lanzavecchia A (2004) Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 22: 745-763.
131. Levy DN, Aldrovandi GM, Kutsch O, Shaw GM (2004) Dynamics of HIV-1 recombination in its natural target cells. Proc Natl Acad Sci U S A 101: 4204- 4209.
132. O'Doherty U, Swiggard WJ, Malim MH (2000) Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J Virol 74: 10074-10080.
133. Meditz AL, Haas MK, Folkvord JM, Melander K, Young R, et al. (2011) HLADR+ CD38+ CD4+ T lymphocytes have elevated CCR5 expression and produce the majority of R5-tropic HIV-1 RNA in vivo. J Virol 85: 10189-10200.
134. Roederer M, Treister A, Moore W, Herzenberg LA (2001) Probability binning comparison: a metric for quantitating univariate distribution differences. Cytometry 45: 37-46.
135. George TC, Fanning SL, Fitzgerald-Bocarsly P, Medeiros RB, Highfill S, et al. (2006) Quantitative measurement of nuclear translocation events using similarity analysis of multispectral cellular images obtained in flow. J Immunol Methods 311: 117-129.
136. Maguire O, Collins C, O'Loughlin K, Miecznikowski J, Minderman H (2011) Quantifying nuclear p65 as a parameter for NF-kappaB activation: Correlation between ImageStream cytometry, microscopy, and Western blot. Cytometry A 79: 461-469.
137. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
138. Ledderose C, Heyn J, Limbeck E, Kreth S (2011) Selection of reliable reference genes for quantitative real-time PCR in human T cells and neutrophils. BMC Res Notes 4: 427.